Tuesday, 04 May 2021 08:49 AM MYT
A nurse shows a vial of the Pfizer-BioNTech Covid-19 vaccine at the Santo Tomas Hospital, in Panama City, Panama February 17, 2021. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
NEW YORK, May 4 The US Food and Drug Administration is preparing to authorise Pfizer Inc and German partner BioNTech SE’s Covid-19 vaccine for adolescents aged between 12 and 15 years by early next week, the
New York Times reported on Monday, citing federal officials familiar with the agency’s plans.
An approval is highly anticipated after the drugmakers said in March that the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial.
Germany
New-york
United-states
Santo-tomas
Chiriquím
Panama
Panama-city
Panamám
German
Biontech-covid
Rochelle-walensky
Us-centers-for-disease-control